Revolution Medicines, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2020 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Revolution Medicines, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2020 to Q2 2024.
  • Revolution Medicines, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 2, 2024 was 167M shares, a 53% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 167M +57.9M +53% Aug 2, 2024 10-Q 2024-08-07
Q1 2024 165M +58.7M +55.2% May 2, 2024 10-Q 2024-05-08
Q3 2023 110M +20.8M +23.4% Nov 1, 2023 10-Q 2023-11-06
Q2 2023 109M +21.5M +24.5% Aug 3, 2023 10-Q 2023-08-08
Q1 2023 106M +32.1M +43.2% May 4, 2023 10-Q 2023-05-08
Q3 2022 88.8M +15.1M +20.5% Nov 2, 2022 10-Q 2022-11-07
Q2 2022 87.7M +14.1M +19.2% Aug 4, 2022 10-Q 2022-08-09
Q1 2022 74.2M +803K +1.09% May 4, 2022 10-Q 2022-05-09
Q3 2021 73.7M +7.31M +11% Nov 4, 2021 10-Q 2021-11-10
Q2 2021 73.6M +7.65M +11.6% Aug 6, 2021 10-Q 2021-08-11
Q1 2021 73.4M +14.4M +24.5% May 5, 2021 10-Q 2021-05-10
Q3 2020 66.4M Nov 9, 2020 10-Q 2020-11-12
Q2 2020 65.9M Aug 5, 2020 10-Q 2020-08-10
Q1 2020 59M May 8, 2020 10-Q 2020-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.